Home › Funds › Arrowstreet Capital › APT
Arrowstreet Capital position in APT
ALPHA PRO TECH LTD · Health Care
Latest position (Q2 2026)58.31K sh
Reported value held$327.70K
Portfolio Weight0.00%
First reportedQ1 2024
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 76.66K | $478 | New |
| Q2 2024 | 68.50K | $377 | Reduce |
| Q3 2024 | 63.80K | $363.67K | Reduce |
| Q4 2024 | 60.73K | $321.27K | Reduce |
| Q1 2025 | 58.31K | $291.55K | Reduce |
| Q2 2025 | 58.31K | $273.47K | Hold |
| Q3 2025 | 58.31K | $279.01K | Hold |
| Q4 2025 | 58.31K | $258.89K | Hold |
| Q1 2026 | 58.31K | $258.89K | Hold |
| Q2 2026 | 58.31K | $327.70K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding APT
- Renaissance Technologies 561.57K sh · $3.16M · Q2 2026
- Citadel Advisors 511.80K sh · $2.88M · Q2 2026
- Vanguard Group 609.07K sh · $2.70M · Q4 2025
- BlackRock Inc 278.69K sh · $1.57M · Q2 2026
- Geode Capital Management 96.85K sh · $545.00K · Q2 2026
- Marshall Wace 52.11K sh · $292.87K · Q2 2026
- Northern Trust Corp 20.70K sh · $116.32K · Q2 2026
- Morgan Stanley 8.07K sh · $45.33K · Q2 2026
- UBS Group AG 5.76K sh · $32.38K · Q2 2026
- Fidelity Management & Research (FMR) 400 sh · $2.25K · Q2 2026
- JPMorgan Chase & Co 131 sh · $727 · Q2 2026